5Preoteasa D, Mocanu C.Efficacy of ophthalmic suspension of Brinzolamide(Azopt) in the primary or combined therapy for patients with hypertensive glaucomas[ J]. Oftalmologia, 2001,54(4): 20.
6Sall K. The efficacy and safety of brinzolamide 1% ophthalmic suspension(Azopt)as a primary therapy in patients with open-angle glaucoma or ocular hypertension[ J ]. Surv Ophthalmol, 2000,44(2): s155.
7Silver LH. Clinical efficacy and safety of brinzolamide(Azopt), a new topical carbonic anhydrase in hibitor for primary open-angle glaucoma and ocular hypertension[J]. Am J Ophthalmol, 1998,126(3) :400.
8March WF, Ochsner KI.The long-term safety and efficacy of brinzolamide 1.0% (Azopt)in patients with primary open-angle glaucoma or ocular hypertension The Brinzolamide Long-Term Therapy Study Group [J] .Am J Ophthalmol, 2000 ,129 ( 2 ) : 136.
9Shin D.Brinzolamide Adjunctive Therapy Study Group. Adjunctive therapy with brinzolamide 1% ophthalmic suspension in paients with open-angle or ocular hypertension maintained on timolol therapy[ J].Surv Ophthalmol , 2000,44: S163.
6Byles DB, Frith P, Salmon JF.Anterior uveitis as a side effect of topical brimonidine[J]. AmercianJof Ophthalmology, 2000, 130(3) : 287.
7Schuman JS, Katz GJ, Lewis RA, et al .Efficacy and safety of affixed combination of travoproprost 0.004%/ timolol 0.5% ophthalmic solution once daily for openangle glaucoma or ocular hypertension[J] .Am J Ophthalmol, 2005,140(2) : 242.
8Ramakrishnan,Arul,Soni ,Anil Kumar,ADH] KARI,Sujit Das. ,et al. Process for preparing Brinzolamide[ P]. WO 2010/103115A1,2010 -09 - 16.
9Dean William D, Zinke Paul W, Sproull StevenL J. , et al. Preparation of carbonic anhydrase inhibitors [ P ]. US 5, 344,929,1994 - 09 - 06.
10Falchi, Alessandro, Delucchi, Ottofino, Castellin, Andrea. Process for the preparation of brinzolamide[P]. W02010/ 004457A2,2010 - 01 - 14.
